American Health Policy Institute
News

Mark Wilson Named One of Washington’s “Most Influential People”

For the second year in a row, HR Policy Association and the American Health Policy Institute’s Mark Wilson was named by Washingtonian Magazine as one of policy experts on health care issues.

In its selection process, the Washingtonian “sought out smart, innovative people who care about issues and spend a lot of time thinking about them. They have deep subject-matter expertise and significant understanding of how DC works, with the goal of getting action. They comprehend policy’s nuances and complexities. And yes, they’re all wonks in one way or another.”

The Washingtonian pointed to Mark’s leadership regarding COVID and the EEOC, noting he “locked heads with the Equal Employment Opportunity Commission over the incentives businesses may offer employees to get vaccinated, urging more specific guidance.” As President of the American Health Policy Institute, [DC1] [TB2] Mark has helped inform the policy debates for many health care issues, such as the Cadillac tax repeal, price transparency, prescription drug pricing, surprise medical billing, HSAs, COBRA subsidies, ACA regulations, and employee wellbeing. 

HR Policy President and CEO Tim Bartl said, “We congratulate Mark on this well-deserved recognition. That he was named for a second year demonstrates his ongoing influence and respect in the Washington policy community. Mark’s leadership on both health care and employment policy is an invaluable asset to the Association and our members at a pivotal time in critical policy areas, including COVID policy, behavioral health, and drug pricing. We look forward to his continued influence and leadership as we navigate the road ahead.”

 

Margaret Faso

Director of Health Care Research and Policy, American Health Policy Institute and HR Policy Association

Detailed Bio

Contact Margaret Faso LinkedIn

MORE NEWS STORIES

Warren Urges Using Patent Authority to Reduce Drug Prices
Federal Health Care Reform

Warren Urges Using Patent Authority to Reduce Drug Prices

April 29, 2022 | News